Open Access Research article

Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study

Charissa Borja-Tabora1, Cecilia Montalban2, Ziad A Memish3*, Marie Van der Wielen4, Veronique Bianco4, Dominique Boutriau4 and Jacqueline Miller5

Author Affiliations

1 Research Institute for Tropical Medicine, Muntinlupa City, Philippines

2 Philippine General Hospital Manila, Manila, Philippines

3 College of Medicine, Alfaisal University, PO Box 54146, Riyadh, 11514, Saudi Arabia

4 GlaxoSmithKline Vaccines, Wavre, Belgium

5 GlaxoSmithKline Vaccines, King of Prussia, PA, USA

For all author emails, please log on.

BMC Infectious Diseases 2013, 13:116  doi:10.1186/1471-2334-13-116

Published: 5 March 2013

Additional files

Additional file 1: Table S1:

Percentage of participants per age strata with an rSBA vaccine response.

Format: PDF Size: 38KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data

Additional file 2: Table S2:

Percentage of participants per age strata with rSBA titres ≥1:8 and 1:128 and GMTs.

Format: PDF Size: 50KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data